Literature DB >> 26522009

Predictive Factors for Positive Margin and the Surgical Learning Curve in Non-Palpable Breast Cancer After Wire-Guided Localization - Prospective Study of 214 Consecutive Patients.

Dezső Tóth1, Zsolt Varga2, Éva Sebő3, Miklós Török4, Ilona Kovács4.   

Abstract

To investigate the most commonly used technique, the wire-guided localization (WGL) in non-palpable breast cancer. To analyze the effective factors on positive surgical margins in our practice and determine the surgical learning curve of this method. Prospective consecutive study was performed from January 2005 to December 2011. Inclusion criteria was a non-palpable breast lesion with malignancy on preoperative histology. All lesions were localized by ultrasound or stereotactic guided wire placement. Margins 1 mm or closer were accepted as positive margins which required re-excision. To determine the learning curve of WGL method we investigated the change in the reoperation rate after primary procedure performed by "high-volume" surgeon. Two hundred and fourteen consecutive patients were enrolled. In 23 patients (10.7%) reexcision was needed. Positive surgical margins were significantly influenced by the patient's age (p = 0.03), tumor volume (p < =0.001), proportion of tumor volume/specimen volume (p < 0.001), presence of DCIS (p < 0.001), multifocality (p = 0.03) and the learning curve (p = 0.006) with univariate analysis. Only the tumor volume, presence of DCIS and the learning curve were proved as independent prognostic factor for reoperation by multivariate analysis. The reoperation rate decreased below 20% after the fortieth operation. Results of our single institutional study suggest, that this localization technique can be performed safely with very good results after 40 procedures as a learning curve for surgeons.

Entities:  

Keywords:  Breast cancer; Learning curve; Non-palpable; Surgery; Wire-guided localization

Mesh:

Year:  2015        PMID: 26522009     DOI: 10.1007/s12253-015-9999-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  25 in total

1.  Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.

Authors:  Melanie C Smitt; Kate Horst
Journal:  Ann Surg Oncol       Date:  2007-01-04       Impact factor: 5.344

Review 2.  Localization of nonpalpable breast lesions.

Authors:  Emily L Postma; Arjen J Witkamp; Maurice Aaj van den Bosch; Helena M Verkooijen; Richard van Hillegersberg
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

3.  Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.

Authors:  E L Postma; H M Verkooijen; S van Esser; M G Hobbelink; G P van der Schelling; R Koelemij; A J Witkamp; C Contant; P J van Diest; S M Willems; I H M Borel Rinkes; M A A J van den Bosch; W P Mali; R van Hillegersberg
Journal:  Breast Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.872

4.  Palpable breast cancers are inherently different from nonpalpable breast cancers.

Authors:  K A Skinner; H Silberman; R Sposto; M J Silverstein
Journal:  Ann Surg Oncol       Date:  2001-10       Impact factor: 5.344

5.  Transection of the localization hooked wire during breast biopsy.

Authors:  M J Homer
Journal:  AJR Am J Roentgenol       Date:  1983-11       Impact factor: 3.959

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality.

Authors:  R G Blanks; S M Moss; C E McGahan; M J Quinn; P J Babb
Journal:  BMJ       Date:  2000-09-16

8.  Radioguided occult lesion localisation versus wire-guided lumpectomy in the treatment of non-palpable breast lesions.

Authors:  Tibor Takács; Attila Paszt; Zsolt Simonka; Szabolcs Abrahám; Bernadett Borda; Aurél Ottlakán; Katalin Ormándi; Máté Lázár; András Vörös; Zsuzsanna Kahán; Gyorgy Lazar
Journal:  Pathol Oncol Res       Date:  2012-10-14       Impact factor: 3.201

9.  Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial.

Authors:  Koray Ocal; Ahmet Dag; Ozgur Turkmenoglu; Emel Ceylan Gunay; Erdem Yucel; Meltem Nass Duce
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Reoperation rates after breast conserving surgery for breast cancer among women in England: retrospective study of hospital episode statistics.

Authors:  R Jeevan; D A Cromwell; M Trivella; G Lawrence; O Kearins; J Pereira; C Sheppard; C M Caddy; J H P van der Meulen
Journal:  BMJ       Date:  2012-07-12
View more
  4 in total

1.  Ultrasound-guided preoperative localization of breast lesions: a good choice.

Authors:  Giorgio Carlino; Pierluigi Rinaldi; Michela Giuliani; Rossella Rella; Enida Bufi; Federico Padovano; Chiara Ciardi; Maurizio Romani; Paolo Belli; Riccardo Manfredi
Journal:  J Ultrasound       Date:  2018-10-26

2.  Trainees participation in breast cancer surgery: an assistance or a hinderance?

Authors:  Geok Hoon Lim
Journal:  Gland Surg       Date:  2019-12

3.  Relationship between BI-RADS and the Results of the Wire-Guided Percutaneous Localization for Non-Palpable Breast Lesions.

Authors:  Mohamad Dughayli; Jason DeFatta; Ayda Dashtaei; Amber Peace; Fadi Baidoun; Gregory Olson
Journal:  Spartan Med Res J       Date:  2019-07-01

4.  A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial).

Authors:  Tae-Kyung Yoo; Young-Joon Kang; Joon Jeong; Jeong-Yoon Song; Sun Hee Kang; Hye Yoon Lee; Eui Tae Kim; Onvox Yi; Han-Byoel Lee; Soojeong Choi; Hyung Seok Park; Geumhee Gwak; Jae Il Kim; Min Kyoon Kim; Jeeyeon Lee; Hee Joon Kang; Byung Joo Chae
Journal:  J Breast Cancer       Date:  2021-12       Impact factor: 3.588

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.